NASDAQ:QDEL - Quidel Stock Price, Forecast & News

Quidel trades on the NASDAQ under the ticker symbol "QDEL."

Quidel Co. (NASDAQ:QDEL) issued its quarterly earnings results on Wednesday, February, 12th. The company reported $1.00 EPS for the quarter, topping the consensus estimate of $0.82 by $0.18. The company earned $152.20 million during the quarter, compared to analyst estimates of $148 million. Quidel had a net margin of 13.63% and a return on equity of 22.71%. The firm's revenue was up 14.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.80 EPS. View Quidel's Earnings History.

Quidel is scheduled to release their next quarterly earnings announcement on Wednesday, May 13th 2020. View Earnings Estimates for Quidel.

Quidel updated its fourth quarter 2019 After-Hours earnings guidance on Thursday, January, 9th. The company provided EPS guidance of for the period. The company issued revenue guidance of $151-152 million, compared to the consensus revenue estimate of $139.17 million.

4 Wall Street analysts have issued 1 year price targets for Quidel's shares. Their forecasts range from $75.00 to $92.00. On average, they expect Quidel's stock price to reach $79.75 in the next twelve months. This suggests a possible upside of 0.5% from the stock's current price. View Analyst Price Targets for Quidel.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Quidel in the last year. There are currently 3 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Quidel.

News articles about QDEL stock have trended negative this week, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Quidel earned a daily sentiment score of -2.1 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 2.0 out of 10, meaning that recent press coverage is very unlikely to have an impact on the stock's share price in the near term. View News Stories for Quidel.

Quidel saw a decrease in short interest in the month of January. As of January 31st, there was short interest totalling 1,920,000 shares, a decrease of 18.3% from the January 15th total of 2,350,000 shares. Based on an average trading volume of 213,200 shares, the short-interest ratio is presently 9.0 days. Currently, 5.2% of the shares of the company are sold short. View Quidel's Current Options Chain.

Some companies that are related to Quidel include Align Technology (ALGN), Cooper Companies (COO), DENTSPLY SIRONA (XRAY), West Pharmaceutical Services (WST), Haemonetics (HAE), ICU Medical (ICUI), Neogen (NEOG), Merit Medical Systems (MMSI), STAAR Surgical (STAA), Atrion (ATRI), Cerus (CERS), Anika Therapeutics (ANIK), Antares Pharma (ATRS), OraSure Technologies (OSUR) and Utah Medical Products (UTMD).

Based on aggregate information from My MarketBeat watchlists, some companies that other Quidel investors own include Netflix (NFLX), Intel (INTC), Alibaba Group (BABA), Adobe (ADBE), NVIDIA (NVDA), Gilead Sciences (GILD), Mastercard (MA), Advanced Micro Devices (AMD), Cisco Systems (CSCO) and Energy Transfer LP Unit (ET).

Quidel's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Fred Alger Management LLC (4.01%), ArrowMark Colorado Holdings LLC (2.87%), State Street Corp (2.09%), New York State Common Retirement Fund (1.80%), Eagle Asset Management Inc. (1.39%) and Geode Capital Management LLC (1.20%). Company insiders that own Quidel stock include Charles P Slacik, Douglas C Bryant, Edward Keith Russell, Karen Gibson, Kenneth F Buechler, Mary Lake Ph D Polan, Michael Donald Jr Abney, Randall J Steward, Ratan S Borkar, Robert Joseph Bujarski, Thomas D Brown and Werner Kroll. View Institutional Ownership Trends for Quidel.

QDEL stock was sold by a variety of institutional investors in the last quarter, including Marshall Wace North America L.P., Marshall Wace LLP, Goldman Sachs Group Inc., Chicago Equity Partners LLC, Gabelli Funds LLC, Chartwell Investment Partners LLC, Rothschild & Co. Asset Management US Inc. and Investment Management of Virginia LLC. Company insiders that have sold Quidel company stock in the last year include Charles P Slacik, Douglas C Bryant, Edward Keith Russell, Karen Gibson, Kenneth F Buechler, Michael Donald Jr Abney, Randall J Steward, Ratan S Borkar and Werner Kroll. View Insider Buying and Selling for Quidel.

QDEL stock was purchased by a variety of institutional investors in the last quarter, including Bridger Management LLC, Public Employees Retirement Association of Colorado, BNP PARIBAS ASSET MANAGEMENT Holding S.A., Royce & Associates LP, ArrowMark Colorado Holdings LLC, Prudential Financial Inc., Fred Alger Management LLC and Barclays PLC. View Insider Buying and Selling for Quidel.

Shares of QDEL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of QDEL stock can currently be purchased for approximately $79.39.

Quidel has a market capitalization of $3.32 billion and generates $534.89 million in revenue each year. The company earns $72.92 million in net income (profit) each year or $2.73 on an earnings per share basis. Quidel employs 1,250 workers across the globe.View Additional Information About Quidel.

The official website for Quidel is http://www.quidel.com/.

Quidel's mailing address is 9975 SUMMERS RIDGE ROAD, SAN DIEGO CA, 92121. The company can be reached via phone at 858-552-1100 or via email at [email protected]